The effects of probiotic and synbiotic supplementation on inflammatory markers among patients with diabetes: A systematic review and meta-analysis of randomized controlled trials.
Diabetes
Inflammatory markers
Meta-analysis
Probiotic
Synbiotic
Journal
European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354
Informations de publication
Date de publication:
05 Jun 2019
05 Jun 2019
Historique:
received:
18
01
2019
revised:
28
03
2019
accepted:
02
04
2019
pubmed:
9
4
2019
medline:
4
9
2019
entrez:
9
4
2019
Statut:
ppublish
Résumé
This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to evaluate the effect of probiotic and symbiotic supplementation on inflammatory markers among patients with diabetes. Clinical trials were searched using Cochrane Library, EMBASE, PubMed, and Web of Science online databases for relevant trials published until April 2018. Two independent investigators evaluated study eligibility, extracted data, and assessed risk of bias of included clinical trials. Cochran's Q test and I-square (I
Identifiants
pubmed: 30959049
pii: S0014-2999(19)30231-6
doi: 10.1016/j.ejphar.2019.04.003
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
254-264Informations de copyright
Copyright © 2019. Published by Elsevier B.V.